{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:11:44Z","timestamp":1788639104645,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100024065","name":"OM Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13300-026-01891-3","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:07:48Z","timestamp":1786342068000},"page":"1313-1331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 2 Diabetes Mellitus and Chronic Venous Disease of the Lower Extremities: A Narrative Review"],"prefix":"10.1007","volume":"17","author":[{"given":"Juan Rosas","family":"Saucedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Gonz\u00e1lez","family":"Villordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Laparra","family":"Escare\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma Areli Rivera","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Fernando Flota","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Sinay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Rosas","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6272-5010","authenticated-orcid":false,"given":"Daniel","family":"Zingg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"1891_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et\u00a0al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1891_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMc1706291","volume":"377","author":"EJ Mayer-Davis","year":"2017","unstructured":"Mayer-Davis EJ, Dabelea D, Lawrence JM. Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012. N Engl J Med. 2017;377(3):301.","journal-title":"N Engl J Med"},{"issue":"2","key":"1891_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jvs.2008.03.041","volume":"48","author":"RB McLafferty","year":"2008","unstructured":"McLafferty RB, Passman MA, Caprini JA, Rooke TW, Markwell SA, Lohr JM, et\u00a0al. Increasing awareness about venous disease: the American Venous Forum expands the national venous screening program. J Vasc Surg. 2008;48(2):394\u20139.","journal-title":"J Vasc Surg"},{"issue":"4","key":"1891_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.113.006898","volume":"130","author":"RT Eberhardt","year":"2014","unstructured":"Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):333\u201346.","journal-title":"Circulation"},{"issue":"Suppl 1","key":"1891_CR5","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1177\/0003319703054001S04","volume":"54","author":"A Jawien","year":"2003","unstructured":"Jawien A. The influence of environmental factors in chronic venous insufficiency. Angiology. 2003;54(Suppl 1):S19-31.","journal-title":"Angiology"},{"issue":"3","key":"1891_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.33549\/physiolres.935033","volume":"72","author":"R Jaro\u0161\u00edkov\u00e1","year":"2023","unstructured":"Jaro\u0161\u00edkov\u00e1 R, Rozto\u010dil K, Hus\u00e1kov\u00e1 J, Dubsk\u00fd M, B\u00e9m R, Woskov\u00e1 V, et\u00a0al. Chronic venous disease and its intersections with diabetes mellitus. Physiol Res. 2023;72(3):280\u20136. https:\/\/doi.org\/10.33549\/physiolres.935033.","journal-title":"Physiol Res"},{"issue":"5","key":"1891_CR7","first-page":"538","volume":"15","author":"B Santler","year":"2017","unstructured":"Santler B, Goerge T. Chronic venous insufficiency\u2014A review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017;15(5):538\u201356.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1891_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1749-6632.2001.tb03932.x","volume":"947","author":"BC Berk","year":"2001","unstructured":"Berk BC, Abe JI, Min W, Surapisitchat J, Yan C. Endothelial atheroprotective and anti-inflammatory mechanisms. Ann N Y Acad Sci. 2001;947:93\u2013109 (discussion-11).","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1891_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4239\/wjd.v5.i4.444","volume":"5","author":"I Mart\u00edn-Tim\u00f3n","year":"2014","unstructured":"Mart\u00edn-Tim\u00f3n I, Sevillano-Collantes C, Segura-Galindo A, Del Ca\u00f1izo-G\u00f3mez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5(4):444\u201370. https:\/\/doi.org\/10.4239\/wjd.v5.i4.444. (PMID:25126392; PMCID:PMC4127581).","journal-title":"World J Diabetes"},{"issue":"1","key":"1891_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","volume":"21","author":"CX Ma","year":"2022","unstructured":"Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21(1):74. https:\/\/doi.org\/10.1186\/s12933-022-01516-6. (PMID:35568946; PMCID:PMC9107726).","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1891_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/dmrr.2551","volume":"30","author":"J Zhong","year":"2014","unstructured":"Zhong J, Chen J, Zhao ZG, He HB, Yan ZC, Liu DY, et\u00a0al. Diabetes mellitus is associated with early chronic venous disorder of the lower extremities in Chinese patients with cardiometabolic risk factors. Diabetes Metab Res Rev. 2014;30(6):505\u201312.","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"1891_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.diabet.2010.04.003","volume":"36","author":"P Pajunen","year":"2010","unstructured":"Pajunen P, Rissanen H, H\u00e4rk\u00e4nen T, Jula A, Reunanen A, Salomaa V. The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 study. Diabetes Metab. 2010;36(5):395\u2013401.","journal-title":"Diabetes Metab"},{"issue":"1","key":"1891_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/VHRM.S4248","volume":"5","author":"C Cola","year":"2009","unstructured":"Cola C, Brugaletta S, Mart\u00edn Yuste V, Campos B, Angiolillo DJ, Sabat\u00e9 M. Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization. Vasc Health Risk Manag. 2009;5(1):101\u201319.","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"1891_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1258\/026835503322381315","volume":"18","author":"A Jawien","year":"2003","unstructured":"Jawien A, Grzela T, Ochwat A. Prevalence of chronic venous insufficiency in men and women in Poland: multicentre cross-sectional study in 40,095 patients. Phlebology. 2003;18(3):110\u201322.","journal-title":"Phlebology"},{"issue":"4","key":"1891_CR15","first-page":"329","volume":"56","author":"S Kaspar","year":"2010","unstructured":"Kaspar S. Veins and diabetes. Vnitr Lek. 2010;56(4):329\u201332.","journal-title":"Vnitr Lek"},{"issue":"5","key":"1891_CR16","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/biomedicines13051076","volume":"13","author":"J Dawi","year":"2025","unstructured":"Dawi J, Tumanyan K, Tomas K, Misakyan Y, Gargaloyan A, Gonzalez E, et\u00a0al. Diabetic foot ulcers: pathophysiology, immune dysregulation, and emerging therapeutic strategies. Biomedicines. 2025;13(5):1076. https:\/\/doi.org\/10.3390\/biomedicines13051076. (PMID: 40426903; PMCID: PMC12109115).","journal-title":"Biomedicines"},{"issue":"1","key":"1891_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.23736\/S0392-9590.16.03736-6","volume":"36","author":"V Fejfarov\u00e1","year":"2017","unstructured":"Fejfarov\u00e1 V, Rozto\u010dil K, Sv\u011bd\u00ednkov\u00e1 A, \u010cerm\u00e1kov\u00e1 H, Dubsk\u00fd M, B\u00e9m R, et\u00a0al. The relationship between chronic venous insufficiency and diabetes mellitus. Int Angiol. 2017;36(1):90\u20131.","journal-title":"Int Angiol"},{"issue":"6","key":"1891_CR18","first-page":"853","volume":"3","author":"HA Hadi","year":"2007","unstructured":"Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3(6):853\u201376 (PMID: 18200806; PMCID: PMC2350146).","journal-title":"Vasc Health Risk Manag."},{"key":"1891_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaa017","volume":"8","author":"A Wang","year":"2020","unstructured":"Wang A, Lv G, Cheng X, Ma X, Wang W, Gui J, et\u00a0al. Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition). Burns Trauma. 2020;8:tkaa017. https:\/\/doi.org\/10.1093\/burnst\/tkaa017.","journal-title":"Burns Trauma"},{"issue":"1","key":"1891_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","volume":"17","author":"C Rask-Madsen","year":"2013","unstructured":"Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17(1):20\u201333. https:\/\/doi.org\/10.1016\/j.cmet.2012.11.012. (PMID: 23312281; PMCID: PMC3546345).","journal-title":"Cell Metab"},{"key":"1891_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, et\u00a0al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Sig Transduct Target Ther. 2023;8:152. https:\/\/doi.org\/10.1038\/s41392-023-01400-z.","journal-title":"Sig Transduct Target Ther"},{"issue":"19","key":"1891_CR22","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.3390\/jcm12196153","volume":"12","author":"A Stanek","year":"2023","unstructured":"Stanek A, Mosti G, Nematillaevich TS, Valesky EM, Planin\u0161ek Ru\u010digaj T, Boucelma M, et\u00a0al. No more venous ulcers-what more can we do? J Clin Med. 2023;12(19):6153. https:\/\/doi.org\/10.3390\/jcm12196153. (PMID: 37834797; PMCID: PMC10573394).","journal-title":"J Clin Med"},{"issue":"4","key":"1891_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/00368504251384189","volume":"108","author":"LF Flota-Cervera","year":"2025","unstructured":"Flota-Cervera LF, Gonz\u00e1lez-Garc\u00eda FJ, Raffoul-Orozco AK, Zingg D, Casta\u00f1\u00f3n G, Zavaleta M. Classification of capillary damage in patients with type 2 diabetes mellitus: Clinical parameters obtained through capillaroscopy\u2014A cross-sectional study. Sci Prog. 2025;108(4):00368504251384189. https:\/\/doi.org\/10.1177\/00368504251384189.","journal-title":"Sci Prog"},{"issue":"1","key":"1891_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12933-023-02056-3","volume":"22","author":"D Mauricio","year":"2023","unstructured":"Mauricio D, Gratac\u00f2s M, Franch-Nadal J. Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves. Cardiovasc Diabetol. 2023;22(1):314. https:\/\/doi.org\/10.1186\/s12933-023-02056-3. (PMID: 37968679; PMCID: PMC10652502).","journal-title":"Cardiovasc Diabetol"},{"issue":"15","key":"1891_CR25","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.3390\/jcm10153239","volume":"10","author":"MA Ortega","year":"2021","unstructured":"Ortega MA, Fraile-Mart\u00ednez O, Garc\u00eda-Montero C, \u00c1lvarez-Mon MA, Chaowen C, Ruiz-Grande F, et\u00a0al. Understanding chronic venous disease: a critical overview of its pathophysiology and medical management. J Clin Med. 2021;10(15):3239. https:\/\/doi.org\/10.3390\/jcm10153239. (PMID: 34362022; PMCID: PMC8348673).","journal-title":"J Clin Med"},{"issue":"8","key":"1891_CR26","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.3390\/ijms26083660","volume":"26","author":"H Abrashev","year":"2025","unstructured":"Abrashev H, Abrasheva D, Nikolov N, Ananiev J, Georgieva E. A systematic review of endothelial dysfunction in chronic venous disease-inflammation, oxidative stress, and shear stress. Int J Mol Sci. 2025;26(8):3660. https:\/\/doi.org\/10.3390\/ijms26083660. (PMID: 40332237; PMCID: PMC12026777).","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1891_CR27","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/ijms19061669","volume":"19","author":"A Mansilha","year":"2018","unstructured":"Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy. Int J Mol Sci. 2018;19(6):1669.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1891_CR28","first-page":"303","volume":"83","author":"AC Frati-Munari","year":"2013","unstructured":"Frati-Munari AC. Medical significance of endothelial glycocalyx. Arch Cardiol Mex. 2013;83(4):303\u201312.","journal-title":"Arch Cardiol Mex"},{"key":"1891_CR29","unstructured":"Flota-Cervera LFP-JJ, Guevara-Sald\u00edvar MI, Mu\u00f1oz-Mart\u00ednez TC, Nuricumbo-V\u00e1zquez A, Santana-Vega D, Ib\u00e1\u00f1ez-Rodr\u00edguez JF, Cardoso-Villase\u00f1or A, Estrada-Guerrero JG, Chew-Salas E, Frati-Munari AC. Sulodexida para la enfermedad venosa cr\u00f3nica. Experiencia cl\u00ednica en M\u00e9xico. Rev Mex Angiol. 2014(1):28\u201337."},{"issue":"6","key":"1891_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.23736\/S0392-9590.17.03805-6","volume":"36","author":"LF Flota Cervera","year":"2017","unstructured":"Flota Cervera LF, Frati Munari AC, Vel\u00e1zquez Herrera \u00c1E, Carbajal CA. Chronic venous disease treated with sulodexide: a survey among primary care physicians in Mexico. Int Angiol. 2017;36(6):558\u201364.","journal-title":"Int Angiol"},{"key":"1891_CR31","first-page":"1","volume":"3","author":"ACF Munari","year":"2015","unstructured":"Munari ACF, Fern L, Cervera O. Inflammation, metalloproteinases, chronic venous disease and sulodexide. J Cardiovasc Dis Diagn. 2015;3:1\u20137.","journal-title":"J Cardiovasc Dis Diagn"},{"key":"1891_CR32","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s42399-021-00809-3","volume":"3","author":"G Dimitrova","year":"2021","unstructured":"Dimitrova G, Lutty GA. The role of retinal venous congestion in diabetic retinopathy. SN Compr Clin Med. 2021;3:964\u201370.","journal-title":"SN Compr Clin Med"},{"key":"1891_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13167-015-0027-1","volume":"6","author":"AK Cybulska-Heinrich","year":"2015","unstructured":"Cybulska-Heinrich AK, et\u00a0al. Patients with diabetic retinopathy have high retinal venous pressure. EPMA J. 2015;6:5.","journal-title":"EPMA J"},{"issue":"15","key":"1891_CR34","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3390\/nu14153086","volume":"14","author":"J Lee","year":"2022","unstructured":"Lee J, Yun JS, Ko SH. Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus. Nutrients. 2022;14(15):3086. https:\/\/doi.org\/10.3390\/nu14153086. (PMID:35956261; PMCID:PMC9370094).","journal-title":"Nutrients"},{"issue":"1","key":"1891_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0741-5214(03)00134-4","volume":"38","author":"KJ Woodside","year":"2003","unstructured":"Woodside KJ, Hu M, Burke A, Murakami M, Pounds LL, Killewich LA, et\u00a0al. Morphologic characteristics of varicose veins: possible role of metalloproteinases. J Vasc Surg. 2003;38(1):162\u20139.","journal-title":"J Vasc Surg"},{"issue":"2","key":"1891_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jvs.2008.03.004","volume":"48","author":"JD Raffetto","year":"2008","unstructured":"Raffetto JD, Qiao X, Koledova VV, Khalil RA. Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: potential implications in varicose veins. J Vasc Surg. 2008;48(2):447\u201356.","journal-title":"J Vasc Surg"},{"issue":"2","key":"1891_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.advms.2016.11.007","volume":"62","author":"A Kuryliszyn-Moskal","year":"2017","unstructured":"Kuryliszyn-Moskal A, Zarzycki W, Dubicki A, Moskal D, Koszty\u0142a-Hojna B, Hryniewicz A. Clinical usefulness of videocapillaroscopy and selected endothelial cell activation markers in people with type 1 diabetes mellitus complicated by microangiopathy. Adv Med Sci. 2017;62(2):368\u201373. https:\/\/doi.org\/10.1016\/j.advms.2016.11.007.","journal-title":"Adv Med Sci"},{"issue":"2","key":"1891_CR38","first-page":"105","volume":"31","author":"E Rabe","year":"2012","unstructured":"Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez QF. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105\u201315.","journal-title":"Int Angiol"},{"issue":"9","key":"1891_CR39","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.3390\/ijms24097910","volume":"24","author":"E Gusev","year":"2023","unstructured":"Gusev E, Sarapultsev A. Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci. 2023;24(9):7910. https:\/\/doi.org\/10.3390\/ijms24097910. (PMID: 37175617; PMCID: PMC10178362).","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1891_CR40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jvsv.2019.12.075","volume":"8","author":"F Lurie","year":"2020","unstructured":"Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, et\u00a0al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8(3):342\u201352.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"1891_CR41","unstructured":"Abid A, Hosseinzadeh S. Foot Ulcer. StatPearls. Treasure Island: StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.; 2025."},{"key":"1891_CR42","unstructured":"Nelson EA, Adderley U. Venous leg ulcers. BMJ Clin Evid. 2016;2016:1902."},{"issue":"3","key":"1891_CR43","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4103\/2229-5178.137819","volume":"5","author":"B Vasudevan","year":"2014","unstructured":"Vasudevan B. Venous leg ulcers: pathophysiology and classification. Indian Dermatol Online J. 2014;5(3):366\u201370.","journal-title":"Indian Dermatol Online J"},{"issue":"16","key":"1891_CR44","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMra1615243","volume":"377","author":"AJ Singer","year":"2017","unstructured":"Singer AJ, Tassiopoulos A, Kirsner RS. Evaluation and management of lower-extremity ulcers. N Engl J Med. 2017;377(16):1559\u201367.","journal-title":"N Engl J Med"},{"issue":"3","key":"1891_CR45","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4103\/2229-5178.137830","volume":"5","author":"R Rai","year":"2014","unstructured":"Rai R. Standard guidelines for management of venous leg ulcer. Indian Dermatol Online J. 2014;5(3):408\u201311.","journal-title":"Indian Dermatol Online J"},{"issue":"6","key":"1891_CR46","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ejvs.2015.02.007","volume":"49","author":"C Wittens","year":"2015","unstructured":"Wittens C, Davies AH, B\u00e6kgaard N, Broholm R, Cavezzi A, Chastanet S, et\u00a0al. Editor\u2019s choice\u2014Management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49(6):678\u2013737.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"1891_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/aje\/kwg166","volume":"158","author":"MH Criqui","year":"2003","unstructured":"Criqui MH, Jamosmos M, Fronek A, Denenberg JO, Langer RD, Bergan J, et\u00a0al. Chronic venous disease in an ethnically diverse population: the San Diego Population study. Am J Epidemiol. 2003;158(5):448\u201356.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"1891_CR48","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jvs.2008.04.029","volume":"48","author":"U Maurins","year":"2008","unstructured":"Maurins U, Hoffmann BH, L\u00f6sch C, J\u00f6ckel KH, Rabe E, Pannier F. Distribution and prevalence of reflux in the superficial and deep venous system in the general population\u2014Results from the Bonn Vein study. Germany J Vasc Surg. 2008;48(3):680\u20137.","journal-title":"Germany J Vasc Surg"},{"issue":"11","key":"1891_CR49","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1001\/archderm.139.11.1409","volume":"139","author":"J Cabrera","year":"2003","unstructured":"Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139(11):1409\u201316.","journal-title":"Arch Dermatol"},{"key":"1891_CR50","unstructured":"Bone C, editor. Tratamiento endoluminal de las varices con laser de Diodo. Estudio preliminar1999."},{"issue":"3","key":"1891_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/153857440003400303","volume":"34","author":"JG Chandler","year":"2000","unstructured":"Chandler JG, Pichot O, Sessa C, Schuller-Petrovic\u0107 S, Kabnick LS, Bergan JJ. Treatment of primary venous insufficiency by endovenous saphenous vein obliteration. Vasc Surg. 2000;34(3):201\u201314.","journal-title":"Vasc Surg"},{"issue":"3","key":"1891_CR52","first-page":"193","volume":"27","author":"H Partsch","year":"2008","unstructured":"Partsch H, Flour M, Smith PC. Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scientific evidence. Under the auspices of the IUP. Int Angiol. 2008;27(3):193\u2013219.","journal-title":"Int Angiol"},{"issue":"4","key":"1891_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/0268355517695401","volume":"33","author":"S Ercan","year":"2018","unstructured":"Ercan S, \u00c7etin C, Yavuz T, Demir HM, Atalay YB. Effects of isokinetic calf muscle exercise program on muscle strength and venous function in patients with chronic venous insufficiency. Phlebology. 2018;33(4):261\u20136.","journal-title":"Phlebology"},{"issue":"12","key":"1891_CR54","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/archsurg.136.12.1364","volume":"136","author":"YM Kan","year":"2001","unstructured":"Kan YM, Delis KT. Hemodynamic effects of supervised calf muscle exercise in patients with venous leg ulceration: a prospective controlled study. Arch Surg. 2001;136(12):1364\u20139.","journal-title":"Arch Surg"},{"issue":"1","key":"1891_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/iwj.12571","volume":"14","author":"J O'Brien","year":"2017","unstructured":"O\u2019Brien J, Finlayson K, Kerr G, Edwards H. Evaluating the effectiveness of a self-management exercise intervention on wound healing, functional ability and health-related quality of life outcomes in adults with venous leg ulcers: a randomised controlled trial. Int Wound J. 2017;14(1):130\u20137.","journal-title":"Int Wound J"},{"key":"1891_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-5945-14-16","volume":"14","author":"JA O'Brien","year":"2014","unstructured":"O\u2019Brien JA, Finlayson KJ, Kerr G, Edwards HE. Testing the effectiveness of a self-efficacy based exercise intervention for adults with venous leg ulcers: protocol of a randomised controlled trial. BMC Dermatol. 2014;14:16.","journal-title":"BMC Dermatol"},{"issue":"5","key":"1891_CR57","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jvs.2012.02.060","volume":"56","author":"S Couzan","year":"2012","unstructured":"Couzan S, Leizorovicz A, Laporte S, Mismetti P, Pouget JF, Chapelle C, et\u00a0al. A randomized double-blind trial of upward progressive versus degressive compressive stockings in patients with moderate to severe chronic venous insufficiency. J Vasc Surg. 2012;56(5):1344-1350.e1. https:\/\/doi.org\/10.1016\/j.jvs.2012.02.060.","journal-title":"J Vasc Surg"},{"issue":"1","key":"1891_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/026835550001500106","volume":"15","author":"YK Vandongen","year":"2000","unstructured":"Vandongen YK, Stacey MC. Graduated compression elastic stockings reduce lipodermatosclerosis and ulcer recurrence. Phlebology. 2000;15(1):33\u20137.","journal-title":"Phlebology"},{"key":"1891_CR59","unstructured":"Health Quality Ontario. Compression stockings for the prevention of venous leg ulcer recurrence: a health technology assessment. Ont Health Technol Assess Ser. 2019;19(2):1\u201386."},{"issue":"1","key":"1891_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001316","volume":"8","author":"U Rother","year":"2020","unstructured":"Rother U, Grussler A, Griesbach C, Almasi-Sperling V, Lang W, Meyer A. Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease. BMJ Open Diabetes Res Care. 2020;8(1):e001316. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001316. (PMID:32503811; PMCID:PMC7279622).","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1891_CR61","doi-asserted-by":"crossref","unstructured":"Mauck KF, Asi N, Elraiyah TA, Undavalli C, Nabhan M, Altayar O, et\u00a0al. Comparative systematic review and meta-analysis of compression modalities for the promotion of venous ulcer healing and reducing ulcer recurrence. J Vasc Surg. 2014;60(2 Suppl):71S\u201390S.e1\u20132.","DOI":"10.1016\/j.jvs.2014.04.060"},{"issue":"11","key":"1891_CR62","volume":"11","author":"MJ Martinez-Zapata","year":"2020","unstructured":"Martinez-Zapata MJ, Vernooij RW, Simancas-Racines D, Uriona Tuma SM, Stein AT, Moreno Carriles RMM, et\u00a0al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev. 2020;11(11):Cd003229.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1891_CR63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejvs.2021.12.024","volume":"63","author":"MG De Maeseneer","year":"2022","unstructured":"De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, et\u00a0al. Editor\u2019s choice\u2014European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184\u2013267. https:\/\/doi.org\/10.1016\/j.ejvs.2021.12.024.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"1891_CR64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/0268355515586097","volume":"31","author":"E Rabe","year":"2016","unstructured":"Rabe E, Ballarini S, Lehr L. A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency. Phlebology. 2016;31(4):264\u201374.","journal-title":"Phlebology"},{"issue":"3","key":"1891_CR65","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ejvs.2007.08.012","volume":"35","author":"MJ Mart\u00ednez-Zapata","year":"2008","unstructured":"Mart\u00ednez-Zapata MJ, Moreno RM, Gich I, Urr\u00fatia G, Bonfill X. A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease. Eur J Vasc Endovasc Surg. 2008;35(3):358\u201365.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"1891_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1258\/0268355041753380","volume":"19","author":"K-H Labs","year":"2004","unstructured":"Labs K-H, Degischer S, Gamba G, Jaeger KA. Effectiveness and safety of calcium dobesilate in treating chronic venous insufficiency: randomized, double-blind, placebo-controlled trial. Phlebology. 2004;19(3):123\u201330.","journal-title":"Phlebology"},{"issue":"4","key":"1891_CR67","first-page":"243","volume":"52","author":"W Vanscheidt","year":"2002","unstructured":"Vanscheidt W, Jost V, Wolna P, L\u00fccker PW, M\u00fcller A, Theurer C, et\u00a0al. Efficacy and safety of a Butcher\u2019s broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency. Arzneimittelforschung. 2002;52(4):243\u201350.","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"1891_CR68","first-page":"309","volume":"33","author":"AA Ramelet","year":"2005","unstructured":"Ramelet AA, Boisseau MR, Allegra C, Nicolaides A, Jaeger K, Carpentier P, et\u00a0al. Veno-active drugs in the management of chronic venous disease. An international consensus statement: current medical position, prospective views and final resolution. Clin Hemorheol Microcirc. 2005;33(4):309\u201319.","journal-title":"Clin Hemorheol Microcirc"},{"key":"1891_CR69","first-page":"15","volume":"1","author":"JDGC Espinosa","year":"2001","unstructured":"Espinosa JDGC. Tratamiento de la insuficiencia venosa cronica con dobesilato de calico. Un meta-analisis. Flebologia. 2001;1:15\u201320.","journal-title":"Flebologia"},{"issue":"4","key":"1891_CR70","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1258\/phleb.2010.010051","volume":"26","author":"E Rabe","year":"2011","unstructured":"Rabe E, Jaeger KA, Bulitta M, Pannier F. Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial. Phlebology. 2011;26(4):162\u20138.","journal-title":"Phlebology"},{"issue":"2","key":"1891_CR71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/000331970405500206","volume":"55","author":"A Ciapponi","year":"2004","unstructured":"Ciapponi A, Laffaire E, Roqu\u00e9 M. Calcium dobesilate for chronic venous insufficiency: a systematic review. Angiology. 2004;55(2):147\u201354.","journal-title":"Angiology"},{"issue":"3","key":"1891_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/02683555241286367","volume":"40","author":"O Arslanturk","year":"2025","unstructured":"Arslanturk O, Uymaz B, Gumus F. Which dose of calcium dobesilate is more effective and safe in chronic venous insufficiency? Multicenter retrospective clinical trial. Phlebology. 2025;40(3):167\u201373.","journal-title":"Phlebology"},{"issue":"3","key":"1891_CR73","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/0003319707305407","volume":"59","author":"F Flota-Cervera","year":"2008","unstructured":"Flota-Cervera F, Flota-Ruiz C, Trevi\u00f1o C, Berber A. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease. Angiology. 2008;59(3):352\u20136.","journal-title":"Angiology"},{"key":"1891_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0268355517692221","volume":"32","author":"R Bush","year":"2017","unstructured":"Bush R, Comerota A, Meissner M, Raffetto JD, Hahn SR, Freeman K. Recommendations for the medical management of chronic venous disease: the role of micronized purified flavanoid fraction (MPFF). Phlebology. 2017;32:3\u201319.","journal-title":"Phlebology"},{"issue":"2","key":"1891_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.23736\/S0392-9590.18.03975-5","volume":"37","author":"SK Kakkos","year":"2018","unstructured":"Kakkos SK, Nicolaides AN. Efficacy of micronized purified flavonoid fraction (Daflon\u00ae) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol. 2018;37(2):143\u201354.","journal-title":"Int Angiol"},{"issue":"1","key":"1891_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23736\/S0392-9590.25.05536-1","volume":"45","author":"S Gianesini","year":"2026","unstructured":"Gianesini S, Danese M, Pagano M, et\u00a0al. Multi-specialty recommendations for the appropriate and affordable lower limb vein-lymphatic disorders management. Int Angiol. 2026;45(1):1\u201364. https:\/\/doi.org\/10.23736\/S0392-9590.25.05536-1.","journal-title":"Int Angiol"},{"issue":"3","key":"1891_CR77","doi-asserted-by":"publisher","first-page":"181","DOI":"10.23736\/S0392-9590.18.03999-8","volume":"37","author":"A Nicolaides","year":"2018","unstructured":"Nicolaides A, Kakkos S, Baekgaard N, Comerota A, de Maeseneer M, Eklof B, et\u00a0al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angiol. 2018;37(3):181\u2013254.","journal-title":"Int Angiol"},{"key":"1891_CR78","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","volume":"48","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res. 2015;48:160\u201380.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"1891_CR79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11427-014-4792-1","volume":"58","author":"X Zhang","year":"2015","unstructured":"Zhang X, Liu W, Wu S, Jin J, Li W, Wang N. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis. Sci China Life Sci. 2015;58(1):101\u20137.","journal-title":"Sci China Life Sci"},{"issue":"3","key":"1891_CR80","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1159\/000495491","volume":"51","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Qi C, Li S, Shao X, Mou S, Ni Z. Diabetic nephropathy can be treated with calcium dobesilate by alleviating the chronic inflammatory state and improving endothelial cell function. Cell Physiol Biochem. 2018;51(3):1119\u201333.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"1891_CR81","first-page":"5012","volume":"14","author":"L Qin","year":"2017","unstructured":"Qin L, Qin W, Wang J, Lin L. Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate. Exp Ther Med. 2017;14(5):5012\u20136.","journal-title":"Exp Ther Med"},{"issue":"2","key":"1891_CR82","first-page":"143","volume":"39","author":"K Han","year":"2018","unstructured":"Han K, Liu C, Shi X, Rao X. Effects of alprostadil combined with calcium dobesilate in patients with diabetic peripheral neuropathy. Neuro Endocrinol Lett. 2018;39(2):143\u20137.","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"1891_CR83","doi-asserted-by":"publisher","first-page":"94","DOI":"10.23736\/S0392-9590.25.05389-1","volume":"44","author":"G Gastaldi","year":"2025","unstructured":"Gastaldi G, Zingg D, Calabrese A, Bouskela E, Van Rijn MJ, Bozkurt K, et\u00a0al. Clinical evidence of venoactive drugs in diabetic microvascular complications: a scoping review. Int Angiol. 2025;44(2):94\u2013109. https:\/\/doi.org\/10.23736\/S0392-9590.25.05389-1.","journal-title":"Int Angiol"},{"key":"1891_CR84","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.lfs.2019.02.023","volume":"221","author":"J Liu","year":"2019","unstructured":"Liu J, Li S, Sun D. Calcium dobesilate and micro-vascular diseases. Life Sci. 2019;221:348\u201353.","journal-title":"Life Sci"},{"key":"1891_CR85","doi-asserted-by":"crossref","unstructured":".Njau F, Shushakova N, Schenk H, Wulfmeyer VC, Bollin R, Menne J, et\u00a0al. Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice. PLoS One. 2020;15(1):e0218494.","DOI":"10.1371\/journal.pone.0218494"},{"key":"1891_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108615","volume":"112","author":"S Patel","year":"2019","unstructured":"Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother. 2019;112:108615.","journal-title":"Biomed Pharmacother"},{"key":"1891_CR87","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.lfs.2019.02.023","volume":"221","author":"J Liu","year":"2019","unstructured":"Liu J, Li S, Sun D. Calcium dobesilate and micro-vascular diseases. Life Sci. 2019;221:348\u201353. https:\/\/doi.org\/10.1016\/j.lfs.2019.02.023.","journal-title":"Life Sci"},{"issue":"5","key":"1891_CR88","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/0268355519895669","volume":"35","author":"C Vitale","year":"2020","unstructured":"Vitale C, Lucchi M, Bissacco D, Bilancini S, D\u2019Abate F, Santoliquido A. Expert consensus on the conservative management of patients with chronic venous disease in CEAP clinical classes C0s\u2013C3 in Italy. Phlebology. 2020;35(5):316\u201324.","journal-title":"Phlebology"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01891-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-026-01891-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01891-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:02:32Z","timestamp":1788638552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-026-01891-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1007\/s13300-026-01891-3","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Juan Rosas Guzman and Dr. Juan Rosas Saucedo have received honoraria from OM Pharma. Dr. Isaac Sinay, Dr. Luis Fernando Flota Cervera, Dr. David Gonz\u00e1lez Villordo, Dr. Hugo Laparra Escare\u00f1o, and Dr. Norma Areli Rivera Garc\u00eda report no conflict of interest. Daniel Zingg is an employee of OM Pharma and receives economic compensation for his work.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review is based on previously published studies and does not involve any new studies with human participants or animals conducted by the authors. Therefore, formal ethical approval was not required.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}